Evolus Revenue 2016-2020 | EOLS
Evolus revenue from 2016 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Evolus Annual Revenue (Millions of US $) |
|
|---|---|
| 2019 | $35 |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| Evolus Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2020-03-31 | $10 |
| 2019-12-31 | $19 |
| 2019-09-30 | $13 |
| 2019-06-30 | $2 |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.185B | $0.035B |
| Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $163.141B | 28.29 |
| Medtronic (MDT) | Ireland | $124.955B | 20.30 |
| Stryker (SYK) | United States | $68.946B | 22.38 |
| Boston Scientific (BSX) | United States | $49.509B | 23.28 |
| Baxter (BAX) | United States | $44.233B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $39.871B | 0.00 |
| Terumo (TRUMY) | Japan | $29.963B | 38.30 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.693B | 0.00 |
| ResMed (RMD) | United States | $27.846B | 43.94 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.894B | 15.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.257B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $16.924B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $13.589B | 61.86 |
| Insulet (PODD) | United States | $12.687B | 1256.94 |
| DiaSorin S.p.A (DSRLF) | Italy | $10.994B | 0.00 |
| Quidel (QDEL) | United States | $9.535B | 74.93 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $8.773B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.523B | 13.46 |
| Hill-Rom Holdings (HRC) | United States | $7.426B | 20.93 |
| GN STORE NORD (GNNDY) | Denmark | $6.972B | 35.54 |
| William Demant Holdings (WILYY) | Denmark | $6.296B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.771B | 0.00 |
| Haemonetics (HAE) | United States | $4.656B | 27.96 |
| Neogen (NEOG) | United States | $4.108B | 69.58 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.892B | 0.00 |
| ICU Medical (ICUI) | United States | $3.890B | 28.38 |
| Agios Pharmaceuticals (AGIO) | United States | $3.836B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.805B | 0.00 |
| Envista Holdings (NVST) | United States | $3.407B | 0.00 |
| NuVasive (NUVA) | United States | $2.925B | 23.49 |
| National Vision Holdings (EYE) | United States | $2.458B | 42.53 |
| TG Therapeutics (TGTX) | United States | $2.213B | 0.00 |
| AtriCure (ATRC) | United States | $1.855B | 0.00 |
| MacroGenics (MGNX) | United States | $1.450B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.390B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.322B | 0.00 |
| Aphria (APHA) | Canada | $1.231B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.137B | 0.00 |
| Cerus (CERS) | United States | $1.109B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.055B | 21.02 |
| Meridian Bioscience (VIVO) | United States | $1.019B | 38.37 |
| PetIQ (PETQ) | United States | $1.017B | 29.37 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.924B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 18.97 |
| Vapotherm (VAPO) | United States | $0.881B | 0.00 |
| Zynex (ZYXI) | United States | $0.834B | 83.73 |
| Omeros (OMER) | United States | $0.826B | 0.00 |
| Quanterix (QTRX) | United States | $0.789B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.746B | 150.25 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.663B | 47.51 |
| Surmodics (SRDX) | United States | $0.585B | 70.49 |
| VAREX IMAGING (VREX) | United States | $0.584B | 14.51 |
| Lantheus Holdings (LNTH) | United States | $0.579B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $0.532B | 30.29 |
| BioLife Solutions (BLFS) | United States | $0.467B | 163.46 |
| Owens & Minor (OMI) | United States | $0.464B | 12.27 |
| Viemed Healthcare (VMD) | United States | $0.367B | 32.55 |
| Cytosorbents (CTSO) | United States | $0.361B | 0.00 |
| HEXO (HEXO) | $0.322B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.315B | 22.85 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.304B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.285B | 0.00 |
| Female Health (VERU) | United States | $0.229B | 0.00 |
| Chimerix (CMRX) | United States | $0.196B | 0.00 |
| Bovie Medical (APYX) | United States | $0.185B | 0.00 |
| Surface Oncology (SURF) | United States | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.161B | 0.00 |
| Fonar (FONR) | United States | $0.135B | 11.94 |
| Rockwell Medical (RMTI) | United States | $0.133B | 0.00 |
| United Health Products (UEEC) | United States | $0.131B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.120B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.112B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.109B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.103B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.084B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.082B | 0.00 |
| Nephros (NEPH) | United States | $0.073B | 0.00 |
| United-Guardian (UG) | United States | $0.071B | 16.51 |
| Capricor Therapeutics (CAPR) | United States | $0.065B | 0.00 |
| Brainsway (BWAY) | Israel | $0.065B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.036B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.027B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.022B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.017B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
